Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas |
| |
Authors: | Peter Lindvall Lars-Owe D. Koskinen |
| |
Affiliation: | aDepartment of Neurosurgery, Umea University Hospital, Umeå 901 85, Sweden |
| |
Abstract: | Seventy-one patients from northern Sweden were diagnosed with chronic subdural haematomas (CSDH) and treated at the Department of Neurosurgery at Umeå University Hospital over 12 months. Fifty-four patients with CSDH had a history of head trauma (trauma group), while 17 patients had no previous head trauma (non-trauma group). In the non-trauma group 71% of patients were treated with anticoagulants or antiplatelet aggregation agents (AAA) compared to 18% in the trauma group. Considering only AAA, 59% of the non-trauma patients were treated with these drugs versus 17% of patients in the trauma group. The recurrence rate for all patients was 17%. These findings confirm that the use of anticoagulants and AAA is over-represented in patients with non-traumatic CSDH. In our study, recurrence was not associated with previous use of anticoagulants or AAA. |
| |
Keywords: | Anticoagulants Antiplatelet aggregation agents Subdural haematoma |
本文献已被 ScienceDirect 等数据库收录! |